These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31567395)

  • 21. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible lenalidomide-induced Stevens-Johnson syndrome during treatment for multiple myeloma.
    Boruah PK; Bolesta S; Shetty SM
    Pharmacotherapy; 2011 Sep; 31(9):925. PubMed ID: 21923596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital.
    Duncan KO; Tigelaar RE; Bolognia JL
    J Am Acad Dermatol; 1999 Mar; 40(3):493-6. PubMed ID: 10071329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment.
    Oguri T; Sasada S; Shimizu S; Shigematsu R; Tsuchiya Y; Ishioka K; Takahashi S; Oki K; Kimura Y; Seki R; Hirose S; Nakamura M
    J Investig Med High Impact Case Rep; 2021; 9():23247096211037462. PubMed ID: 34344201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer.
    Pham YTH; Vu MT; Nguyen AQ; Trinh PN; Tran MH; Chu HC; Nguyen NTM; Vu CHV; Nguyen DV
    Asia Pac Allergy; 2024 Jun; 14(2):84-89. PubMed ID: 38827262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pembrolizumab-induced toxic epidermal necrolysis: A rare cause of severe adverse drug reaction.
    Neema S; Sathu S; Vasudevan B; Shreshta S; Bhatt S; K L
    Indian J Dermatol Venereol Leprol; 2023; 89(4):589-591. PubMed ID: 37067146
    [No Abstract]   [Full Text] [Related]  

  • 28. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
    Guleria VS; Sharda C; Rana T; Sood AK
    Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bullous drug reaction after pembrolizumab administration: two case reports].
    Golle L; Michl C; Kreft B
    Dermatologie (Heidelb); 2022 Dec; 73(12):959-964. PubMed ID: 35925211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.
    Haratake N; Tagawa T; Hirai F; Toyokawa G; Miyazaki R; Maehara Y
    J Thorac Oncol; 2018 Nov; 13(11):1798-1799. PubMed ID: 29885481
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Fritsch PO; Sidoroff A
    Am J Clin Dermatol; 2000; 1(6):349-60. PubMed ID: 11702611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson Syndrome Associated With Chlordiazepoxide.
    Jawaro T; Kumar A; Pistun O; Dixit D
    J Pharm Technol; 2018 Apr; 34(2):82-85. PubMed ID: 34860942
    [No Abstract]   [Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color.
    Pierre AB; Jernigan AM; Castellano T
    Gynecol Oncol Rep; 2023 Dec; 50():101290. PubMed ID: 37868017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
    Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
    Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Halted by Etanercept.
    Gavigan GM; Kanigsberg ND; Ramien ML
    J Cutan Med Surg; 2018; 22(5):514-515. PubMed ID: 29421925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
    Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
    J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.